Search Results 121-130 of 7360 for infliximab

  1. Psoriatic arthritis - Diagnosis & treatment - Mayo Clinic

    The medicines include adalimumab (Humira), certolizumab (Cimzia), etanercept (Enbrel) and golimumab (Simponi). They also include infliximab (Remicade), ...

  2. Medical Research & Education - Mayo Clinic News Network

    Crohn's Disease Study on Infliximab, Azathioprine. Shawn Bishop. October 1, 2008. First · Previous ... 348 · 349 · 350 · 351 · Last · Sign up to receive email ...

  3. Vedolizumab IV In Pediatric Participants With Ulcerative Colitis Or Crohn's Disease - Mayo Clinic

    Signs and symptoms of persistently active disease despite a history of at least 1 induction regimen of infliximab 5 mg/kg IV at Week 0 and Weeks 2 and 6 or ...

  4. Medical Research & Education - Mayo Clinic News Network

    Gastroenterology. Crohn's Disease Study on Infliximab, Azathioprine. Shawn Bishop. October 1, 2008. 1 … 361 · 362 · 363 · Sign up to receive email notifications ...

  5. Medical Research & Education - Mayo Clinic News Network

    Researchers revealed what appeared to be two separate health conditions stemmed from a single, shared genetic variant. Latest stories.

  6. Pancolitis - Diagnosis and treatment - Mayo Clinic

    Examples include infliximab (Remicade) ... If symptoms do not improve after several days, medicines such as infliximab or cyclosporine may be used.

  7. Rilonacept (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps ... infliximab (Remicade®) while you are being treated with this medicine ...

  8. Medical Research & Education - Mayo Clinic News Network

    Latest stories. Gastroenterology. Crohn's Disease Study on Infliximab, Azathioprine. Shawn Bishop. October 1, 2008. 1 … 359 · 360 · 361 · Sign up to receive ...

  9. Treatment of IgG4-Related Disease With Revlimid and Rituximab - Mayo Clinic

    Treatment with infliximab, adalimumab, or etanercept within the past 12 months. Currently taking azathioprine, 6-mercaptopurine, methotrexate, mycophenolate ...

  10. A Study To Evaluate The Safety And Effectiveness Of Upadacitinib (ABT-494) In Subjects With Moderately To Severely Active Crohn's Disease - Mayo Clinic

    At least one 6-week induction regimen of infliximab (≥ 5 mg/kg intravenous [IV] at Baseline and Weeks 2, and 6);; At least one 4-week induction regimen of ...